Cargando…

Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

BACKGROUND: Since body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Junyi, Cai, Yaning, Yu, Fangfang, Ping, Zhiguang, Liu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325029/
https://www.ncbi.nlm.nih.gov/pubmed/32600328
http://dx.doi.org/10.1186/s12885-020-07064-0
_version_ 1783552075093770240
author Wang, Junyi
Cai, Yaning
Yu, Fangfang
Ping, Zhiguang
Liu, Li
author_facet Wang, Junyi
Cai, Yaning
Yu, Fangfang
Ping, Zhiguang
Liu, Li
author_sort Wang, Junyi
collection PubMed
description BACKGROUND: Since body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis risk of breast cancer. METHODS: Cohort studies that evaluating BMI and lymph node metastasis in breast cancer were selected through various databases including PubMed, PubMed Central (PMC), Web of science, the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP) and Wanfang Data Knowledge Service Platform (WanFang) until November 30, 2019. The two-stage, random effect meta-analysis was performed to assess the dose-response relationship between BMI and lymph node metastasis risk. Between-study heterogeneity was assessed using I(2). Subgroup analysis was done to find possible sources of heterogeneity. RESULTS: We included a total of 20 studies enrolling 52,904 participants. The summary relative risk (RR) (1.10, 95%CI: 1.06–1.15) suggested a significant effect of BMI on the lymph node metastasis risk of breast cancer. The dose-response meta-analysis (RR = 1.01, 95%CI: 1.00–1.01) indicated a positive linear association between BMI and lymph node metastasis risk. For every 1 kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.89%. In subgroup analyses, positive linear dose-response relationships between BMI and lymph node metastasis risk were observed among Asian, European, American, premenopausal, postmenopausal, study period less than 5 years, and more than 5 years groups. For every 1 kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.99, 0.85, 0.61, 1.44, 1.45, 2.22, and 0.61%, respectively. CONCLUSION: BMI significantly increases the lymph node metastasis risk of breast cancer as linear dose-response reaction. Further studies are needed to identify this association.
format Online
Article
Text
id pubmed-7325029
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73250292020-06-30 Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies Wang, Junyi Cai, Yaning Yu, Fangfang Ping, Zhiguang Liu, Li BMC Cancer Research Article BACKGROUND: Since body mass index (BMI) is a convincing risk factor for breast cancer, it is speculated to be associated with lymph node metastasis. However, epidemiological studies are inconclusive. Therefore, this study was conducted to investigate the effect of BMI on the lymph node metastasis risk of breast cancer. METHODS: Cohort studies that evaluating BMI and lymph node metastasis in breast cancer were selected through various databases including PubMed, PubMed Central (PMC), Web of science, the China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals (VIP) and Wanfang Data Knowledge Service Platform (WanFang) until November 30, 2019. The two-stage, random effect meta-analysis was performed to assess the dose-response relationship between BMI and lymph node metastasis risk. Between-study heterogeneity was assessed using I(2). Subgroup analysis was done to find possible sources of heterogeneity. RESULTS: We included a total of 20 studies enrolling 52,904 participants. The summary relative risk (RR) (1.10, 95%CI: 1.06–1.15) suggested a significant effect of BMI on the lymph node metastasis risk of breast cancer. The dose-response meta-analysis (RR = 1.01, 95%CI: 1.00–1.01) indicated a positive linear association between BMI and lymph node metastasis risk. For every 1 kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.89%. In subgroup analyses, positive linear dose-response relationships between BMI and lymph node metastasis risk were observed among Asian, European, American, premenopausal, postmenopausal, study period less than 5 years, and more than 5 years groups. For every 1 kg/m(2) increment of BMI, the risk of lymph node metastasis increased by 0.99, 0.85, 0.61, 1.44, 1.45, 2.22, and 0.61%, respectively. CONCLUSION: BMI significantly increases the lymph node metastasis risk of breast cancer as linear dose-response reaction. Further studies are needed to identify this association. BioMed Central 2020-06-29 /pmc/articles/PMC7325029/ /pubmed/32600328 http://dx.doi.org/10.1186/s12885-020-07064-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wang, Junyi
Cai, Yaning
Yu, Fangfang
Ping, Zhiguang
Liu, Li
Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title_full Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title_fullStr Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title_full_unstemmed Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title_short Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
title_sort body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325029/
https://www.ncbi.nlm.nih.gov/pubmed/32600328
http://dx.doi.org/10.1186/s12885-020-07064-0
work_keys_str_mv AT wangjunyi bodymassindexincreasesthelymphnodemetastasisriskofbreastcanceradoseresponsemetaanalysiswith52904subjectsfrom20cohortstudies
AT caiyaning bodymassindexincreasesthelymphnodemetastasisriskofbreastcanceradoseresponsemetaanalysiswith52904subjectsfrom20cohortstudies
AT yufangfang bodymassindexincreasesthelymphnodemetastasisriskofbreastcanceradoseresponsemetaanalysiswith52904subjectsfrom20cohortstudies
AT pingzhiguang bodymassindexincreasesthelymphnodemetastasisriskofbreastcanceradoseresponsemetaanalysiswith52904subjectsfrom20cohortstudies
AT liuli bodymassindexincreasesthelymphnodemetastasisriskofbreastcanceradoseresponsemetaanalysiswith52904subjectsfrom20cohortstudies